Tim Illidge - Dissemin

Papers authored by Tim Illidge

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2016 Debayan Mukherjee, Tim Illidge

, Jamie Honeychurch

Modelling the immunological response to clinically relevant radiotherapy in a murine prostate tumour model

Upload

This paper is made freely available by the publisher.

Simon J. Dovedi, Grazyna Lipowska-Bhalla, Stephen A. Beers, Eleanor J. Cheadle, Lijun Mu, Martin J. Glennie, Timothy M. Illidge

, Jamie Honeychurch

Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CD8+ T cells

Download from cancerimmunolres.aacrjournals.org

This paper is available in a repository.

Sridhar Chaganti, Tim Illidge

, Sally Fiona Barrington

, Pam Mckay, Kim M. Linton, Kate Cwynarski, Andrew McMillan, Andy Davies, Simon Stern, Karl Peggs, British Committee for Standards in Haematology

Guidelines for the management of diffuse large B-cell lymphoma

Download from discovery.ucl.ac.uk

Simon J. Dovedi, Amy L. Adlard, Yosuke Ota, Masashi Murata, Eiji Sugaru, Erina Koga-Yamakawa, Ken Eguchi, Yuko Hirose, Setsuko Yamamoto, Hiroki Umehara, Jamie Honeychurch, Eleanor J. Cheadle, Gareth Hughes, Philip J. Jewsbury, Robert W. Wilkinson

and 2 other authors

Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.

Download from doi.org

E. A. Zagadailov, S. Corman, M. Hagan, V. Chirikov, C. Johnson, C. Macahilig, B. Seal, M. R. Dalal, Timothy M. Illidge

, P. J. Brockelmann, P. J. Broeckelmann

Risk factors for relapse in patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant: a real-world analysis in Germany and the United Kingdom.

Upload

E. A. Zagadailov, S. Corman, M. Hagan, V. Chirikov, C. Johnson, C. Macahilig, B. Sea, M. R. Dalal, P. J. Brockelmann, P. J. Broeckelmann, Timothy M. Illidge

Real-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory Hodgkin lymphoma post autologous stem-cell transplantation.

Upload

U. Vitolo, Null on behalf of the Esmo Guidelines Committee, J. F. Seymour, M. Martelli, G. Illerhaus, Timothy M. Illidge

, E. Zucca

, E. Campo, M. Ladetto

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Download from academic.oup.com

Tim M. Illidge

, Hayley S. McKenzie, Sam Mayes, Andrew Bates, Andrew J. Davies, Ruth Pettengell, Louise Stanton, Kelly Cozens, Grace Hampson, Caroline Dive, Maureen Zivanovic, Jill Tipping, Eve Gallop-Evans, John A. Radford, Peter W. M. Johnson

Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2015 Timothy M. Illidge

Turning Radiotherapy into an Effective Systemic Anti-cancer Treatment in Combination with Immunotherapy

Upload

Tim Illidge

, Christian Klein, Laurie H. Sehn, Sehn Lh, Andrew Davies, Gilles Salles, Guillaume Cartron

Obinutuzumab in hematologic malignancies: Lessons learned to date

Upload

Timothy M. Illidge

Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: Have We Got the Balance Right?

Upload

John Radford, Tim Illidge

, Sally Barrington

PET-Directed Therapy for Hodgkin's Lymphoma

Download from www.researchgate.net

John Radford, Tim Illidge

, Sally Fiona Barrington

The authors reply

Upload

Timothy M. Illidge

Personalised approach to treating early Hodgkin's lymphoma

Download from dx.doi.org

Lena Specht

, Bouthaina Dabaja, Tim Illidge

, Lynn D. Wilson, Richard T. Hoppe

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

Download from doi.org

Joachim Yahalom

, Tim Illidge

, Lena Specht, Richard T. Hoppe, Ye-Xiong Li, Richard Tsang, Andrew Wirth

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

Download from www.researchgate.net

Jamie Honeychurch, Eleanor J. Cheadle, Simon J. Dovedi, Timothy M. Illidge

, Cheadle EJ Doveid SJ Illidge Tm Honeychurch J.

Immuno-regulatory antibodies for the treatment of cancer.

Upload

S. J. Dovedi, T. M. Illidge

The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

Download from www.tandfonline.com

Kobe Reynders, Tim Illidge

, Shankar Siva, Joe Y. Chang, Dirk De Ruysscher

The abscopal effect of local radiotherapy: Using immunotherapy to make a rare event clinically relevant

Download from europepmc.org

Maja V. Maraldo, Bouthaina S. Dabaja, Andrea R. Filippi

, Tim Illidge

, Richard Tsang, Umberto Ricardi, Peter M. Petersen, Deborah A. Schut, John Garcia, Jayne Headley, Amy Parent, Benoit Guibord, Riccardo Ragona, Lena Specht

Radiation Therapy Planning for Early-Stage Hodgkin Lymphoma: Experience of the International Lymphoma Radiation Oncology Group.

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Tim Illidge